心臓 56/3 2024年3月号

出版社: 日本医学出版
発行日: 2024-03-15
分野: 臨床医学:内科  >  雑誌
ISSN: 05864488
雑誌名:
電子書籍版: 2024-03-15
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:4~8営業日

2,200 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

目次

  • Open HEART
    高リスク手術の協働意思決定

    HEART’s Selection
    これでいいのか循環器内科の職業被ばくに対する放射線防護
    1. 放射線防護の基礎知識
    2. カテーテル治療医師の視点:放射線被ばく防護の取り組み
    3. 診療放射線技師の視点:カテーテル室とハイブリッド手術室の安全対策
    4  1. SHD領域における心エコー医、麻酔科医、カテーテル術者の放射線被ばくの現状と問題点、その対策
      2. SHD領域における放射線防護の現状―若手女性心エコー医の立場から
    5. 不整脈領域の被ばく対策:現状と取り組みのポイント

    [連載]HEART's Column 特別編
    Authorが語る日本発のクリニカル・エビデンス:
     論文の解説と発表後の展望~欧米学会でのシンポジウム発表と一流誌への論文同時掲載の実際~
    「Edoxaban for 12 Months Versus 3 Months in Cancer Patients With Isolated Distal Deep Vein
      Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial」
    「A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With
      Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial」

    [連載]HEART’s Up To Date
    循環器医が知っておくべき最新のエビデンス

    HEART’s Original
    [臨床研究]
    維持透析患者においてその後のドライウエイト減量を予測する因子の検討
     (血液学的検査と心エコー検査指標との比較検討)

    [臨床報告]
    オンライン会議システムを流用した緊急冠動脈カテーテル治療の遠隔支援

    [症例]
    生前に診断し得た閉塞性壁内冠動脈アミロイドーシスの1例

    [Editorial Comment]
    児玉論文に対するEditorial Comment

    [症例]
    Fontan手術後の左肺動静脈瘻への責任末梢肺動脈塞栓により酸素化の改善を認めた1例

    [Editorial Comment]
    沼﨑論文に対するEditorial Comment

    [Editorial Comment]
    沼﨑論文に対するEditorial Comment
    Fontan手術後の左肺動静脈瘻への責任末梢肺動脈塞栓により酸素化の改善を認めた1例

    [症例]
    aVRとaVL以外の全誘導でST上昇を認めた急性冠症候群の1例

    [Editorial Comment]

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【Open HEART】

P.227 掲載の参考文献
1) Krumholz HM : Post-hospital syndrome--an acquired, transient condition of generalized risk. N Engl J Med 2013 ; 368 : 100-102
2) Whitney SN, McGuire AL, McCullough LB : A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004 ; 1 40 : 5 4-59
3) 日本循環器学会 : 2022年改訂版 非心臓手術における合併心疾患の評価と管理に関するガイドライン. https://www.j-circ.or.jp/cms/wp-contentiuploads/2022/03/JCS2022_hiraoka.pdf (cited 2024 Jan 24)
4) Barnett G. Swart M : Shared decision making for high-risk surgery. BJA Educ 2021 ; 21 : 300-306
5) Mohanty S, Rosenthal RA, Russell MM, et al : Optimal Perioperative Management of the Geriatric Patient : A Best Practices Guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. J Am Coll Surg 2016 ; 222 : 930-947
6) Kruser JM, Nabozny MJ, Steffens NM, et al : "Best Case/Worst Case" : Qualitative Evaluation of a Novel Communication Tool for Difficult in-the-Moment Surgical Decisions. J Am Geriatr Soc 2015 ; 63 : 1805-1811
7) Halpern SD : Goal-Concordant Care -Searching for the Holy Grail. N Engl J Med 2019 ; 381 : 1603-1606
8) Shigetomi K, Hiraoka E, Takahashi M, et al : Feasibility of Nurse-Led Advance Care Planning Before Pre-cardiac Procedures : A Descriptive Study. Cureus 2023 ; 15 : e48347
9) Niburski K, Guadagno E, Mohtashami S, Poenaru D : Shared decision making in surgery : A scoping review of the literature. Health Expect 2020 ; 23 : 1241-1249
10) SDM-Q-9/SDM-Q-Doc : The 9-item Shared Decision Making Questionnaire. https://www.patient-als-partner.de/index.php?article_id=20&clang=2 (cited 2024 Jan 28)
11) 共有意思決定についての質問票 医師用 [SDM-Q-Doc]. https://www.patient-als-partner.de/media/sdm-q-doc_japanese.pdf (cited 2024 Jan 24)

【HEART' s Selection】

P.234 掲載の参考文献
1) 日本アイソトープ協会 : ICRP publication 103 : 国際放射線防護委員会の2007年勧告. 東京 : 日本アイソトープ協会 ; 2009. p.31
2) Preston DL, Ron E, Tokuoka S, et al : Solid cancer incidence in atomic bomb survivors : 1958-1998. Radiat Res 2007 ; 168 : 1-64
3) 放射線審議会 : 放射線防護の基本的考え方の整理-放射線審議会における対応- (令和4年2月改訂). https://www.nra.go.jp/data/000383357.pdf (cited 2024 Feb 01)
4) 厚生労働省労働基準局 安全衛生部労働衛生課長通知 : 放射線障害防止対策に係る都道府県等衛生主管部局との連携について (基安労発0128 第1号 令和3年1月28日). https://www.mhlw.go.jp/content/11300000/000791440.pdf (cited 2024 Feb 03)
5) 厚生労働省労働基準局 安全衛生部長通知 : 放射線業務における眼の水晶体の被ばくに係る放射線障害防止対策について (基安発0418 第2号 平成29年4月18日). https://www.mhlw.go.jp/seisakunitsuite/bunya/koyou_roudou/roudoukijun/anzen/dl/anzeneisei_0418_1-4.pdf (cited 2024 Feb 01)
6) 日本医学放射線学会, 血管造影・インターベンション専門診療放射線技師認定機構, 日本医学物理士会, ほか : 医療スタッフの放射線安全に係るガイドライン~水晶体の被ばく管理を中心に~. https://www.kyoto-msc.jp/news/suishoutai2020/ (cited 2024 Feb 01)
7) 日本医学放射線学会 : 診療用放射線に係る安全管理体制に関するガイドライン (2019年11月改訂). https://www.radiology.jp/content/files/20191128_01.pdf (cited 2024 Feb 01)
P.240 掲載の参考文献
1) 日本循環器学会 : 2021年改訂版 循環器診療における放射線被ばくに関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kozuma.pdf (cited 2024 Jan 27)
2) Kozuma K, Chikamori T, Hashimoto J, et al : JCS 2021 Guideline on Radiation Safety in Cardiology. Circ J 2022 ; 86 : 1148-1203
3) Hirshfeld JW Jr, Ferrari VA, Bengel FM, et al : 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1 : Radiation Physics and Radiation Biology : A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 2018 ; 71 : 2811-2828
4) Sawdy JM, Kempton TM, Olshove V, et al : Use of a dose-dependent follow-up protocol and mechanisms to reduce patients and staff radiation exposure in congenital and structural interventions. Catheter Cardiovasc Interv 2011 ; 78 : 136-142
5) Palena LM, Brocco E, Manzi M : The clinical utility of below-the-ankle angioplasty using "transmetatarsal artery access" in complex cases of CLI. Catheter Cardiovasc Interv 2014 ; 83 : 123-129
6) Best PJ, Skelding KA, Mehran R, et al : SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. Catheter Cardiovasc Interv 2011 ; 77 : 232-341
7) Manzo-Silberman S, Velazquez M, Burgess S, et al : Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy : a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Heart Rhythm Association (EHRA), the European Association of Cardiovascular Imaging (EACVI), the ESC Regulatory Affairs Committee and Women as One. EuroIntervention 2023 ; 19 : 53-62
8) Women As One : Radiation Safety. https://womenasone.org/radiation-safety/ (cited 2024 Jan 26)
P.245 掲載の参考文献
1) 日本アイソトープ協会 : ICRP publication 85 : IVRにおける放射線傷害の回避. 東京 : 日本アイソトープ協会 ; 2003.
2) 医療放射線防護連絡協議会 : IVRに伴う放射線皮膚障害の防止に関するガイドライン-Q&Aと解説-ブックレット・シリーズ 3. 愛知 : 医療放射線防護連絡協議 ; 2004.
3) 日本循環器学会 : 2021年改訂版 循環器診療における放射線被ばくに関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kozuma.pdf (cited 2024 Jan 30)
4) 日本アイソトープ協会 : ICRP publication 73 : IVRにおける放射線傷害の回避. 東京 : 日本アイソトープ協会, 1997.
5) 医療被ばく研究情報ネットワーク : 日本の診断参考レベル (2020年版) 医療被ばく研究情報ネットワーク. https://www.nirs.qst.go.jp/usr/J-RIME/JapanDRL2020_jp.pdf (cited 2024 Jan 30)
6) 武田和也, 林利廣, 先山耕史, ほか : 血管撮影装置のプログラム別のシネ撮影線量およびDSA撮影線量の多施設調査 : 透視線量との比較. 日放線技会誌 2021 ; 77 : 718-725
P.250 掲載の参考文献
1) Kataoka A : Gender and positional disparities between echocardiologists and operators in MitraClip heart teams in Japan. J Echocardiogr 2021 ; 19 : 65-66
2) Kataoka A, Takata T, Yanagawa A, et al : Body Surface Radiation Exposure in Interventional Echocardiographers during Left Atrial Appendage Closure : Monte Carlo Simulation. J Am Soc Echocardiogr 2023 Nov 24 : S0894-7317 (23) 00640-5. doi : 10.1016/j.echo.2023.11.017. [Online ahead of print]
3) Kataoka A, Takata T, Yanagawa A, et al : Body Surface Radiation Exposure in Interventional Echocardiographers During Structural Heart Disease Procedures. JACC Asia 2023 ; 3 : 301-309
4) Crowhurst JA, Scalia GM, Whitby M, et al : Radiation Exposure of Operators Performing Transesophageal Echocardiography During Percutaneous Structural Cardiac Interventions. J Am Coll Cardiol 2018 ; 71 : 1246-1254
5) Yanagawa A, Takata T, Onimaru T, et al : New perforated radiation shield for anesthesiologists : Monte Carlo simulation of effects. J Radiat Res 2023 ; 64 : 379-386
6) Takata T, Kataoka A, Yanagawa A, et al : Simulation of Radiation Dose for Female Physicians : Radiation Exposure Risk in Structural Heart Disease Procedures. J Transcatheter Valve Ther 2023 ; 5 : 17-23
P.255 掲載の参考文献
1) 日本循環器学会 : 2021年改訂版 循環器診療における放射線被ばくに関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kozuma.pdf (cited 2024 Feb 10)
2) Crowhurst JA, Scalia GM, Whitby M, et al : Radiation Exposure of Operators Performing Transesophageal Echocardiography During Percutaneous Structural Cardiac Interventions. J Am Coll Cardiol 2018 ; 71 : 1246-1254
3) 佐藤希美 : 心エコー医の放射線被ばくの現状 : 若手心エコーフェローの会からの報告. 一般社団法人日本心エコー図学会 第33回学術集会. 2022/4/10 ; 米子市
4) Salaun E, Carles S, Bigand E, et al : High Radiation Exposure of the Imaging Specialist During Structural Heart Interventions With Echocardiographic Guidance. JACC Cardiovasc Interv 2017 ; 10 : 626-627
5) Nishizaki F, Shimbo M, Fukue N, et al : National Survey Identifying the Factors Affecting the Career Development of Cardiologists in Japan. Circ J 2023 ; 87 : 1219-1228
6) Abdulsalam N, Gillis AM, Rzeszut AK, et al : Gender Differences in the Pursuit of Cardiac Electrophysiology Training in North America. J Am Coll Cardiol 2021 ; 78 : 898-909
7) Yong CM, Abnousi F, Rzeszut AK, et al : Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training. JACC Cardiovasc Interv 2019 ; 12 : 219-228
P.259 掲載の参考文献
1) National Council on Radiation Protection and Measurements : NCRP Report No.160 : Ionizing Radiation Exposure of the Population of the United States. 2009.
2) National Council on Radiation Protection and Measurements : NCRP Report No.93 : Ionizing Radiation Exposure of the Population of United States. 1987.
3) Picano E, Vano E, Rehani MM, et al : The appropriate and justified use of medical radiation in cardiovascular imaging : a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Eur Heart J 2014 ; 35 : 665-672
4) 日本循環器学会 : 2021年改訂版 循環器診療における放射線被ばくに関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kozuma.pdf (cited 2024 Jan 27)
5) Heidbuchel H, Wittkampf FH, Vano E, et al : Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace 2014 ; 16 : 946-964
6) Seguchi S, Saijo T, Ishikawa Y, Nagao T : Evaluation of Entrance Skin Dose during Catheter Ablation Procedures by Use of Reference Air-Kerma Displayed on Angiography Systems. Pacing Clin Electrophysiol 2016 ; 39 : 235-240
7) Pappone C, Oreto G, Lamberti F, et al : Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999 ; 100 : 1203-1208
8) Rotter M, Takahashi Y, Sanders P, et al : Reduction of fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel anatomical navigation system. Eur Heart J 2005 ; 26 : 1415-1421
9) Kistler PM, Rajappan K, Jahngir M, et al : The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006 ; 17 : 1093-1101
10) Brooks AG, Wilson L, Kuklik P, et al : Image integration using NavX Fusion : initial experience and validation. Heart Rhythm 2008 ; 5 : 526-535
11) Shurrab M, Di Biase L, Briceno DF, et al : Impact of Contact Force Technology on Atrial Fibrillation Ablation : A Meta-Analysis. J Am Heart Assoc 2015 ; 4 : e002476
12) Debreceni D, Janosi K, Bocz B, et al : Zero fluoroscopy catheter ablation for atrial fibrillation : a systematic review and meta-analysis. Front Cardiovasc Med 2023 ; 10 : 1178783
13) Rivera S, Vecchio N, Ricapito P, Ayala-Paredes F : Non-fluoroscopic catheter ablation of arrhythmias with origin at the summit of the left ventricle. J Interv Card Electrophysiol 2019 ; 56 : 279-290
14) Steffel J, Verhamme P, Potpara TS, et al : The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018 ; 39 : 1330-1393
15) Miwa Y, Ueda A, Komeda M, et al : Reducing radiation exposure during atrial fibrillation ablation using lectures to promote awareness. Open Heart 2019 ; 6 : e000982

【連載】

P.265 掲載の参考文献
1) 日本循環器学会 : 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf (cited 2023 Nov 24)
2) Righini M, Galanaud JP, Guenneguez H, et al : Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS) : a randomised, double-blind, placebo-controlled trial. Lancet Haematol 2016 ; 3 : e556-e562
3) Ageno W, Bertu L, Bucherini E, et al : Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis : randomised controlled trial. BMJ 2022 ; 379 : e072623
4) Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T ; ONCO DVT Study Investigators : Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study) : An Open-Label, Multicenter, Randomized Clinical Trial. Circulation 2023 ; 148 : 1665-1676
P.271 掲載の参考文献
1) Pengo V, Lensing AW, Prins MH, et al : Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004 ; 350 (22) : 2257-2264
2) Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al : Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism : a contemporary view of the published literature. Eur Respir Med 2017 ; 49 (2) : 1601792
3) Valerio L, Mavromanoli AC, Barco S, et al : Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism : the FOCUS study. Eur Heart J 2022 ; 43 (36) : 3387-3398
4) Hosokawa K, Abe K, Funakoshi K, et al : Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin : a Japanese prospective cohort study. J Thromb Haemost 2023 ; 21 (8) : 2151-2162
5) Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe K ; KABUKI Investigators : A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension : KABUKI Trial. Circulation 2024 ; 149 : 406-409
6) Harrington J, Piccini JP, Alexander JH, et al : Clinical Evaluation of Factor XIa Inhibitor Drugs : JACC Review Topic of the Week. J Am Coll Cardiol 2023 ; 81 (8) : 771-779

【HEART' s Original】

P.280 掲載の参考文献
1) 桑原守正, 松下和弘, 吉永英俊, ほか : 血液透析患者におけるHANP濃度 (人心房性ナトリウム利尿ペプチド) 測定の臨床的意義-D.W (. ドライウェイト) 決定の指標としてのHANP-. 泌尿紀要 1992 ; 38 : 5-8
2) Celik G, Silinou E, Vo-Van C, et al : Plasma BNP, a useful marker of fluid overload in hospitalized hemodialysis patients. Hemodial Int 2012 ; 16 : 47-52
3) Cristina Di Gioia M, Gascuena R, Gallar P, et al : Echocardiographic findings in haemodialysis patients according to their state of hydration. Nefrologia 2017 ; 37 : 47-53
4) Shibata E, Nagai K, Ueda S, et al : The utility and limitation of inferior vena cava diameter as a dry weight marker. J Med Invest 2019 ; 66 : 172-177
5) Braunschweig F, Kjellstrom B, Soderhall M, et al : Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor. Nephrol Dial Transplant 2006 ; 21 : 176-183
6) Yoo HHB, Dos Reis R, Telini WM, et al : Association of Pulmonary Hypertension With Inflammation and Fluid Overload in Hemodialysis Patients. Iran J Kidney Dis 2017 ; 11 : 303-308
P.288 掲載の参考文献
1) Munich SA, Tan LA, Nogueira DM, et al : Mobile Real-time Tracking of Acute Stroke Patients and Instant, Secure Inter-team Communication-the Join App. Neurointervention 2017 ; 12 : 69-76
2) 厚生労働省 : 医療情報システムの安全管理に関するガイドライン 第6.0版. https://www.mhlw.go.jp/stf/shingi/0000516275_00006.html (cited 2023 May 31)
P.295 掲載の参考文献
1) 児玉圭太, 川人充知, 渡邉祐三, ほか : 閉塞性壁内冠動脈アミロイドーシスの1剖検例. 心臓 2019 ; 51 : 1063-1070
3) Morin J, Schreiber WE, Lee C : Sudden Death due to undiagnosed primary amyloidosis. J Forensic Sci 2013 ; 58 (Suppl 1) : S250-252
4) 腰山宏, 野崎英二, 小野貞英, ほか : 小血管の閉塞による心筋虚血のため重症心不全をきたしたAL typeアミロイドーシスの1例. 心臓 2007 ; 39 : 738-743
5) Kang GH, Ryu DR, Song PS, et al : A Case of a senile systemic amyloidosis patient presenting with angina pectoris and dilated cardiomyopathy. Korean Circ J 2011 ; 41 : 209-212
6) Messroghli DR, Moon JC, Ferreira VM, et al : Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume : A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017 ; 19 : 75
7) Soma K, Takizawa M, Uozumi H, et al : A Case of ST-Elevated Myocardial Infarction Resulting From Obstructive Intramural Coronary Amyloidosis. Int Heart J 2010 ; 51 : 134-136
8) Rapezzi C, Merlini G, Quarta CC, et al : Systemic cardiac amyloidoses : disease profiles and clinical courses of the 3 main types. Circulation 2009 ; 120 : 1203-1212
9) 尾上健児, 中野知哉, 斎藤能彦 : 心アミロイドーシスの病理診断. 医学のあゆみ 2020 ; 275 : 1177-1182
10) Kunadian V, Chieffo A, Camici PG, et al : An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020 ; 41 : 3504-3520
11) Endo J, Sano M, Izumiya Y, et al : A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. Circ J 2019 ; 84 : 15-17
P.297 掲載の参考文献
1) Ogawa H, Mizuno Y, Ohkawara S, et al : Cardiac amyloidosis presenting as microvascular angina--a case report. Angiology 2001 ; 52 : 273-278
2) Cuddy SAM, Bravo PE, Falk RH, et al : Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis : Redefining Early Disease? JACC Cardiovasc Imaging 2020 ; 13 : 1325-1336
3) Choi KH, Lee JM, Kim SR, et al : Prognostic Value of the Index of Microcirculatory Resistance Over Serum Biomarkers in Cardiac Amyloidosis. J Am Coll Cardiol 2020 ; 75 : 560-561
P.306 掲載の参考文献
1) White RI Jr, Lynch-Nyhan A, Terry P, et al : Pulmonary arteriovenous malformations : techniques and long-term outcome of embolotherapy. Radiology 1988 ; 169 : 663-669
2) Nakayama M, Nawa T, Chonan T, et al : Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med 2012 ; 51 : 1677-1681
3) Shioya T, Hashimoto M, Koizumi A, et al : Hereditary hemorrhagic telangiectasia (HHT) in Akita Prefecture, Japan. Intern Med 2000 ; 39 : 675-676
4) Gossage JR, Kanj G : Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998 ; 158 : 643-661
5) Srivastava D, Preminger T, Lock JE, et al : Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 1995 ; 92 : 1217-1222
6) Kavarana MN, Jones JA, Stroud RE, et al : Pulmonary arteriovenous malformations after the superior cavopulmonary shunt : Mechanisms and clinical implications. Expert Rev Cardiovasc Ther 2014 ; 12 : 703-713
7) Trerotola SO, Pyeritz RE : PAVM embolization : an update. AJR Am J Roentgenol 2010 ; 195 : 837-845
8) 藤田修平, 太田邦雄, 山崎治幸, ほか : コイル塞栓術を施行した多発性肺動静脈瘻の1例. 日本小児循環器学会雑誌 2005 ; 21 : 32-39
9) Kirsch LR, Sos TA, Engle MA : Successful coil embolization for diffuse, multiple pulmonary arteriovenous fistulas. Am Heart J 1991 ; 122 : 245-248
10) Nakamura Y, Yagihara T, Kagisaki K, et al : Pulmonary arteriovenous malformations after a Fontan operation in the left isomerism and absent inferior vena cava. Eur J Cardiothorac Surg 2009 ; 36 : 69-76
11) Trusty PM, Restrepo M, Kanter KR, et al : A pulsatile hemodynamic evaluation of the commercially available bifurcated Y-graft Fontan modification and comparison with the lateral tunnel and extracardiac conduits. J Thorac Cardiovasc Surg 2016 ; 151 : 1529-1536
P.308 掲載の参考文献
1) Marcelletti C, Como A, Giannico S, Marino B : Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg 1990 ; 100 : 228-232
2) Faughnan ME, Thabet A, Mei-Zahav M, et al : Pulmonary arteriovenous malformations in children : outcomes of transcatheter embolotherapy. J Pediatr 2004 ; 145 : 826-831
3) 日本小児循環器学会 : 先天性および小児期発症心疾患に対するカテーテル治療の適応ガイドライン. 日小児循環器会誌 2012 ; 28 (Suppl 2)
4) Reidy JF : Pulmonary arterio-venous fistulas. In Sievert H, Qureshi SA, Wilson N, Hijazi ZM (ed) : Percutaneous interventions for congenital heart disease. London : Informa Healthcare ; 2007. p.419-422
P.310 掲載の参考文献
1) Rochon ER, Krowka MJ, Bartolome S, et al : BMP 9/10 in pulmonary vascular complications of liver disease. Am J Respir Crit Care Med 2020 ; 201 : 1575-1578
2) Sakaki S, Hayashi T, Ono H : Pulmonary arteriovenous malformations in a patient with single ventricle and polysplenia syndrome. BMJ Case Rep 2019 ; 12 : e229491
3) White RI Jr, Lynch-Nyhan A, Terry P, et al : Pulmonary arteriovenous malformations : Techniques and long-term outcome of embolotherapy. Radiology 1988 ; 169 : 663-669
4) Trerotola SO, Pyeritz RE : PAVM embolization : an update. AJR Am J Roentgenol 2010 ; 195 : 837-845
5) 鎌田政博 : 肺動静脈瘻に対するコイル塞栓術と奇異性脳塞栓. 日本小児循環器学会雑誌 2005 ; 21 : 40-41
6) Woodward CS, Pyeritz RE, Chittams JL, Trerotola SO : Treated pulmonary arteriovenous malformations : patterns of persistence and associated retreatment success. Radiology 2013 ; 269 : 919-926
7) Milic A, Chan RP, Cohen JH, Faughnan ME : Reperfusion of pulmonary arteriovenous malformations after embolotherapy. J Vasc Interv Radiol 2005 ; 16 : 1675-1683
8) Tau N, Atar E, Mei-Zahav M, et al : Amplatzer vascular plugs versus coils for embolization of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 2016 ; 39 : 1110-1114
9) 下平政史, 太田賢吾, 鈴木一史, ほか : 肺動静脈奇形に対する治療戦略-再発しない塞栓術のために-. 脈管学 2017 ; 57 : 119-123
P.316 掲載の参考文献
1) 明石嘉浩 : たこつぼ心筋障害の臨床像と鑑別疾患. 日心臓核医 2013 ; 15 (3) : 8-9. https://jsnc.org/sites/default/files/202012/jsnc15305.pdf (cited 2023 Mar 24)
2) Prasad A Lerman A Rihal CS : A pical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy) : a mimic of acute myocardial infarction. Am Heart J 2008 ; 155 : 408-417
3) Ghadri JR, Cammann VL, Napp LC, et al : Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome : Data From the International Takotsubo Registry. JAMA Cardiol 2016 ; 1 : 335-340
4) Templin C, Ghadri JR, Diekmann J, et al : Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015 ; 373 : 929-938
5) Kosuge M, Ebina T, Hibi K, et al : Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol 2010 ; 55 : 2514-2516
6) Kim BG, Kim KH, Nah JC, Cho SW : Simultaneous left and right ventricular apical thrombi after occlusion of the wrapped left anterior descending artery. J Cardiol Cases 2019 ; 19 : 153-156
7) Fujii T, Hasegawa M, Nakamura N, Ikari Y : Diagnostic flowchart to estimate the morphology of left descending artery lesions by initial electrocardiogram in ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol 2020 ; 25 : e12695
8) Kurisu S, Inoue I, Kawagoe T, et al : Time course of electrocardiographic changes in patients with tako-tsubo syndrome : comparison with acute myocardial infarction with minimal enzymatic release. Circ J 2004 ; 68 : 77-81
9) Ghadri JR, Wittstein IS, Prasad A, et al : International Expert Consensus Document on Takotsubo Syndrome (Part I) : Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J 2018 ; 39 : 2032-2046
P.317 掲載の参考文献
1) 日本循環器学会 : 急性冠症候群ガイドライン (2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/11/JCS2018_kimura.pdf (cited 2024 Jan 27)
2) Alsagaff MY, Kusumawardhani N : Wrapped left anterior descending artery STEMI : time to revisit. BMJ Case Rep 2021 ; 14 : e237839
3) Ilia R, Rosenshtein G, Weinstein J, et al : Left anterior descending artery length in left and right coronary artery dominance. Coron Artery Dis 2001 ; 12 : 77-78
4) Fujii T, Hasegawa M, Nakamura N, Ikari Y : Diagnostic flowchart to estimate the morphology of left descending artery lesions by initial electrocardiogram in ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol 2020 ; 25 : e12695
5) Perez-Pomares JM, de la Pompa JL, Franco D, et al : Congenital coronary artery anomalies : a bridge from embryology to anatomy and pathophysiology--a position statement of the development, anatomy, and pathology ESC Working Group. Cardiovasc Res 2016 ; 109 : 204-216

最近チェックした商品履歴

Loading...